These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8522300)

  • 1. p53 mediated tumor cell response to chemotherapeutic DNA damage: a preliminary study in matched pairs of breast cancer biopsies.
    Moll UM; Ostermeyer AG; Ahomadegbe JC; Mathieu MC; Riou G
    Hum Pathol; 1995 Dec; 26(12):1293-301. PubMed ID: 8522300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma.
    Byun DS; Chae KS; Ryu BK; Lee MG; Chi SG
    Int J Cancer; 2002 Apr; 98(5):718-23. PubMed ID: 11920641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 in breast cancer subtypes and new insights into response to chemotherapy.
    Bertheau P; Lehmann-Che J; Varna M; Dumay A; Poirot B; Porcher R; Turpin E; Plassa LF; de Roquancourt A; Bourstyn E; de Cremoux P; Janin A; Giacchetti S; Espié M; de Thé H
    Breast; 2013 Aug; 22 Suppl 2():S27-9. PubMed ID: 24074787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract.
    Sheikh MS; Huang Y; Fernandez-Salas EA; El-Deiry WS; Friess H; Amundson S; Yin J; Meltzer SJ; Holbrook NJ; Fornace AJ
    Oncogene; 1999 Jul; 18(28):4153-9. PubMed ID: 10435597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
    Ruiz-Ruiz MC; López-Rivas A
    Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxed cell-cycle arrests and propagation of unrepaired chromosomal damage in cancer cell lines with wild-type p53.
    Olivier M; Bautista S; Vallès H; Theillet C
    Mol Carcinog; 1998 Sep; 23(1):1-12. PubMed ID: 9766432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
    Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
    Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular bases of the antitumor activity of a 7-substituted camptothecin in hormone-refractory human prostate carcinoma models.
    Zuco V; Supino R; De Cesare M; Carenini N; Perego P; Gatti L; Pratesi G; Pisano C; Martinelli R; Bucci F; Zanier R; Carminati P; Zunino F
    Biochem Pharmacol; 2003 Apr; 65(8):1281-94. PubMed ID: 12694869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of G1 checkpoint function by the non-genotoxic carcinogen phenobarbital.
    Gonzales AJ; Christensen JG; Preston RJ; Goldsworthy TL; Tlsty TD; Fox TR
    Carcinogenesis; 1998 Jul; 19(7):1173-83. PubMed ID: 9683175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma.
    Lavarino C; Pilotti S; Oggionni M; Gatti L; Perego P; Bresciani G; Pierotti MA; Scambia G; Ferrandina G; Fagotti A; Mangioni C; Lucchini V; Vecchione F; Bolis G; Scarfone G; Zunino F
    J Clin Oncol; 2000 Dec; 18(23):3936-45. PubMed ID: 11099323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid.
    Zuco V; Zanchi C; Cassinelli G; Lanzi C; Supino R; Pisano C; Zanier R; Giordano V; Garattini E; Zunino F
    Cell Death Differ; 2004 Mar; 11(3):280-9. PubMed ID: 14657960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UCN-01 and camptothecin induce DNA double-strand breaks in p53 mutant tumor cells, but not in normal or p53 negative epithelial cells.
    Jones CB; Clements MK; Redkar A; Daoud SS
    Int J Oncol; 2000 Nov; 17(5):1043-51. PubMed ID: 11029511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic damage and the radiation-induced G1-phase checkpoint.
    Gupta N; Vij R; Haas-Kogan DA; Israel MA; Deen DF; Morgan WF
    Radiat Res; 1996 Mar; 145(3):289-98. PubMed ID: 8927696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
    Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T
    Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HTLV-1 tax oncoprotein attenuates DNA damage induced G1 arrest and enhances apoptosis in p53 null cells.
    Haoudi A; Semmes OJ
    Virology; 2003 Jan; 305(2):229-39. PubMed ID: 12573569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.
    Vikhanskaya F; Erba E; D'Incalci M; Broggini M
    Exp Cell Res; 1996 Sep; 227(2):380-5. PubMed ID: 8831577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New orally active DNA minor groove binding small molecule CT-1 acts against breast cancer by targeting tumor DNA damage leading to p53-dependent apoptosis.
    Saini KS; Hamidullah ; Ashraf R; Mandalapu D; Das S; Siddiqui MQ; Dwivedi S; Sarkar J; Sharma VL; Konwar R
    Mol Carcinog; 2017 Apr; 56(4):1266-1280. PubMed ID: 27813185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis.
    Dou QP; An B; Will PL
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9019-23. PubMed ID: 7568064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of retinoblastoma gene product in p53-mediated DNA damage response.
    Smith ML; Zhan Q; Bae I; Fornace AJ
    Exp Cell Res; 1994 Dec; 215(2):386-9. PubMed ID: 7982477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
    Turner BC; Gumbs AA; Carbone CJ; Carter D; Glazer PM; Haffty BG
    Cancer; 2000 Mar; 88(5):1091-8. PubMed ID: 10699900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.